iiinova — where your digital self keeps evolving

Thrombosis Canada @thrombosiscan.bsky.social · 5h

Symptômes persistants après une EP : à quel moment ne s’agit-il plus simplement de récupération? Vicky Mai : maladie thromboembolique chronique, Sessions Éclair. 7 nov. | Montréal + sur demande Inscrivez-vous d’ici le 14 oct. thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 5h

Persistent symptoms after PE: when is recovery no longer the whole story? Vicky Mai tackles Chronic Thromboembolic Disease during Rapid Fire. Nov. 7 | Montréal + on demand Register by Oct. 14. thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 30/09/2026

Le patient ne correspond pas parfaitement aux recommandations. Que faire? Rapports du matin + de l’après-midi : cas complexes en thrombose. 7 nov. | Montréal + sur demande Tarif régulier jusqu’au 14 oct. thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 30/09/2026

The patient doesn’t fit neatly into the guideline. What now? Morning + Afternoon Reports tackle complex thrombosis consults. Nov. 7 | Montréal + on demand Regular registration closes Oct. 14. thrombosiscanada.ca/2026Conference

001

Thrombosis Canada @thrombosiscan.bsky.social · 27/09/2026

Same patient. Same day. Two different answers. Dr Grégoire Le Gal previews one of the real-world diagnostic challenges he’ll tackle at Thrombosis Unpacked: Decisions That Matter. November 7 | Montréal or on demand afterward thrombosiscanada.ca/2026Conference #PulmonaryEmbolism #Thrombosis

000

Thrombosis Canada @thrombosiscan.bsky.social · 26/09/2026

Votre congrès. Votre choix. Montréal | 7 nov. ou Sur demande après l’événement thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 26/09/2026

Your conference. Your choice. Montréal | Nov. 7 or On demand afterward thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 25/09/2026

L’intervention est prévue. Le patient est anticoagulé. Que faire maintenant? Jameel Abdulrehman et Joseph Shaw abordent l’anticoagulation périopératoire, du cadre général aux scénarios à haut risque. 7 nov. | Montréal + sur demande thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 25/09/2026

The procedure is scheduled. The patient is anticoagulated. Now what? Jameel Abdulrehman and Joseph Shaw tackle perioperative anticoagulation from framework to high-risk scenarios. Nov. 7 | Montréal + on demand thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 23/09/2026

Could factor XIa inhibition change how we think about the balance between preventing thrombosis and bleeding? Dr. Mike Sharma discusses what OCEANIC-STROKE could mean for secondary stroke prevention. Listen to CLOT Conversations: thrombosiscanada.ca/hcp/clot-con... #Stroke #FactorXIa

000

Thrombosis Canada @thrombosiscan.bsky.social · 23/09/2026

Vous ne pouvez pas vous joindre à nous à Montréal? Vous pouvez quand même participer. Joignez-vous à nous à Montréal le 7 novembre ou visionnez le congrès enregistré au moment qui vous convient. Les mêmes frais d’inscription s’appliquent aux deux options. thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 23/09/2026

Can’t join us in Montréal? You can still take part. You can now register for Thrombosis Unpacked: Decisions That Matter and access the full conference on demand afterward. The same registration fee applies to both options. Learn more and register: thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 21/09/2026

Why target factor XIa? Dr. Mike Sharma explains how observations from factor XI deficiency helped lead investigators toward a potentially different approach to antithrombotic therapy. Listen: thrombosiscanada.ca/hcp/clot-con...

000

Thrombosis Canada @thrombosiscan.bsky.social · 20/09/2026

What’s changing in pulmonary embolism care? Conference Co-chair Dr Ben Lai previews why the new PE guidance matters. Nov. 7 | Montréal thrombosiscanada.ca/2026Conference #PulmonaryEmbolism #Thrombosis

000

Thrombosis Canada @thrombosiscan.bsky.social · 19/09/2026

Venez pour les questions cliniques. Restez pour les échanges. Apprendre. Échanger. Connecter. 7 nov. | Montréal thrombosiscanada.ca/2026Conference #Thrombose #FormationMédicale

000

Thrombosis Canada @thrombosiscan.bsky.social · 19/09/2026

Come for the clinical questions. Stay for the conversations. Learn. Discuss. Connect. Nov. 7 | Montréal thrombosiscanada.ca/2026Conference #Thrombosis #MedEd

000

Thrombosis Canada @thrombosiscan.bsky.social · 18/09/2026

Antécédent d’EP. Nouveaux symptômes. Une nouvelle EP est soupçonnée. Les D-dimères peuvent-ils encore être utiles? Bobby Gouin abordera ce défi lors des Sessions Éclair. 7 nov. | Montréal thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 18/09/2026

Previous PE. New symptoms. PE is suspected again. Can D-dimer still help? Bobby Gouin tackles recurrent PE diagnosis during Rapid Fire. Nov. 7 | Montréal thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 17/09/2026

Comment la fonction rénale devrait-elle influencer le choix de l'anticoagulant? Thomas Mavrakanas abordera l’apixaban en présence d’IRC et d’IRT lors des Sessions Éclair. 7 nov. | Montréal thrombosiscanada.ca/2026Conference #Thrombose #Anticoagulation

000

Thrombosis Canada @thrombosiscan.bsky.social · 17/09/2026

How should renal function influence anticoagulant choice? Thomas Mavrakanas tackles Apixaban in CKD and ESRD at this year’s Rapid Fire session. Nov. 7 | Montréal thrombosiscanada.ca/2026Conference #Thrombosis #Anticoagulation

000

Thrombosis Canada @thrombosiscan.bsky.social · 16/09/2026

“We’re going to have to think very differently about this than we have with traditional antithrombotics.” Hear Dr. Sharma discuss OCEANIC-STROKE with Dr. Maha Othman and Dr. Jameel Abdulrehman on CLOT Conversations. thrombosiscanada.ca/hcp/clot-con... #Stroke #Thrombosis #FactorXIa

000

Thrombosis Canada @thrombosiscan.bsky.social · 16/09/2026

Ce soir à 19 h HE : EP aiguë et thrombose associée au cancer : mise à jour. Une discussion fondée sur des cas portant sur la prophylaxie, l’EP aiguë, le risque de saignement et l’anticoagulation prolongée. Il est encore temps de vous inscrire.

000

Thrombosis Canada @thrombosiscan.bsky.social · 15/09/2026

Tonight at 7:00 PM ET: Acute PE and Cancer-associated Thrombosis: Update. Case-based discussion of prophylaxis, acute PE, bleeding risk and extended anticoagulation. Registration is still open. thrombosiscanada.ca/PE&Cancer

000

Thrombosis Canada @thrombosiscan.bsky.social · 14/09/2026

Tomorrow: Acute PE and Cancer-associated Thrombosis. Explore thromboprophylaxis, acute PE treatment, bleeding risk and extended anticoagulation through interactive clinical cases. English: Sept. 15 | French: Sept. 16 1.25 Section 1 hours. thrombosiscanada.ca/PE&Cancer

000

Thrombosis Canada @thrombosiscan.bsky.social · 14/09/2026

EP aiguë et thrombose associée au cancer. Explorez la thromboprophylaxie, le traitement de l’EP aiguë, le risque de saignement et l’anticoagulation prolongée à partir de cas cliniques interactifs. En français : 16 septembre 1,25 heure – section 1 thrombosiscanada.ca/PE&Cancer

000

Thrombosis Canada @thrombosiscan.bsky.social · 14/09/2026

OCEANIC-STROKE: Ischemic stroke Asundexian: 6.2% Placebo: 8.4% HR 0.74 ISTH major bleeding: 1.9% vs 1.7% Dr. Mike Sharma discusses the findings on CLOT Conversations. thrombosiscanada.ca/hcp/clot-con...

000

Thrombosis Canada @thrombosiscan.bsky.social · 13/09/2026

Patients rarely read the rule book. Dr Mark Crowther previews what to expect when some of Canada’s leading thrombosis experts tackle the complicated clinical cases. Thrombosis Unpacked: Decisions That Matter November 7 | Montréal Learn more and register:

000

Thrombosis Canada @thrombosiscan.bsky.social · 13/09/2026

What did OCEANIC-STROKE show about recurrent ischemic stroke? Dr. Mike Sharma, PI for OCEANIC-STROKE, discusses the study’s primary efficacy finding and why the results are important for secondary stroke prevention. Hear the full conversation here: thrombosiscanada.ca/hcp/clot-con...

000

Thrombosis Canada @thrombosiscan.bsky.social · 12/09/2026

Certaines décisions sont tout sauf simples. C'est autour de ce constat que s'articule l'événement *Thrombosis Unpacked: Decisions That Matter*. 7 novembre | Montréal thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 12/09/2026

Some decisions are anything but simple. That’s what Thrombosis Unpacked: Decisions That Matter is built around. November 7 | Montréal thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 11/09/2026

New CLOT Conversations: OCEANIC-STROKE. Dr. Mike Sharma discusses the phase 3 trial of asundexian added to antiplatelet therapy after noncardioembolic ischemic stroke or high-risk TIA. What did it show, and what could it mean for practice? thrombosiscanada.ca/hcp/clot-con...

010

Thrombosis Canada @thrombosiscan.bsky.social · 27/08/2026

New acute PE guidelines. New clinical categories. Practical implications for care. Drs. Lana Castellucci and Kerstin de Wit discuss the 2026 acute PE guideline, from risk assessment and PERT to anticoagulation and advanced therapies. Listen here: thrombosiscanada.ca/hcp/clot-con...

022

Thrombosis Canada @thrombosiscan.bsky.social · 24/07/2026

Five Rapid Fire questions at #TC2026: Anticoagulation and superficial thrombophlebitis Suspicion of chronic thromboembolic disease Kidney function and apixaban decisions Diagnostic uncertainty in PE D-dimer in suspected recurrent PE thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 23/07/2026

La prise en charge de l’EP implique une série de décisions : Quelle est la probabilité clinique? Quel examen choisir? Quel est le niveau de risque? Un traitement ambulatoire est-il possible? Quel suivi est nécessaire? thrombosiscanada.ca/2026Conference Programme en anglais.

000

Thrombosis Canada @thrombosiscan.bsky.social · 23/07/2026

PE management involves a sequence of decisions: How likely is PE? Which test is appropriate? How severe is it? Can the patient be treated as an outpatient? What follow-up is needed? Explore current approaches at #TC2026. buff.ly/kPho3LB

000

Thrombosis Canada @thrombosiscan.bsky.social · 14/07/2026

How would you manage this patient? The day begins with Thrombosis Morning Report: Anxiety-Provoking Thrombosis Consults, an interactive session where leading thrombosis experts work through challenging real-world cases. Join us in Montréal on November 7. Register: thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 07/07/2026

Maintenant agréée par le Collège Royal. Joignez-vous à nous à Montréal le 7 novembre pour la Conférence annuelle d'éducation 2026 de Thrombosis Canada. Inscription : thrombosiscanada.ca/2026Conference #ThrombosisCanada #DPC #Thrombose #FormationMédicale

000

Thrombosis Canada @thrombosiscan.bsky.social · 07/07/2026

Now Royal College accredited for up to 6.5 MOC credits. Join us in Montréal on November 7 for the 2026 Thrombosis Canada Annual Education Conference.A practical, case-based program for healthcare professionals managing thrombosis cases. Register: thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 01/07/2026

Happy Canada Day 2026 to all of our supporters. We hope that you have a great day, in what ever way that you celebrate it!

000

Thrombosis Canada @thrombosiscan.bsky.social · 01/07/2026

Aujourd'hui est la dernière journée pour profiter du tarif préférentiel. Joignez-vous à des collègues de partout au Canada pour le congrès annuel 2026 de Thrombosis Canada. e tarif préférentiel prend fin aujourd'hui. 7 novembre 2026 | Montréal Inscrivez-vous : thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 01/07/2026

Today is the final day to register at the Early Bird rate. Join healthcare professionals from across Canada for Thrombosis Unpacked: Decisions That Matter. Early Bird pricing ends today. November 7, 2026 | Montréal Register now: thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 30/06/2026

Le tarif préférentiel prend fin demain. Vous prévoyez participer au congrès annuel 2026 de Thrombosis Canada à Montréal? C'est le moment de vous inscrire. 7 novembre 2026 | Montréal Inscrivez-vous : thrombosiscanada.ca/2026Conference À noter : Les présentations seront offertes en anglais.

000

Thrombosis Canada @thrombosiscan.bsky.social · 30/06/2026

Early Bird registration ends tomorrow (July1). If you're planning to join us in Montréal this November, now is the time to register. The 2026 Thrombosis Canada Annual Education Conference brings together leading experts from across Canada November 7, 2026 thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 29/06/2026

Should hormone therapy automatically be stopped after a diagnosis of thrombosis? In this clip from CLOT Conversations, Dr. Shannon Bates discusses why the answer is often no, and why individualized decision-making remains critical. Full episode: www.buzzsprout.com/1946680/epis...

000

Thrombosis Canada @thrombosiscan.bsky.social · 26/06/2026

Le tarif préférentiel prend fin le 1er juillet. Vous pensez participer au congrès annuel 2026 de Thrombosis Canada à Montréal? C'est le moment idéal pour réserver votre place. buff.ly/ut1Fj5O À noter : Les présentations seront offertes en anglais.

000

Thrombosis Canada @thrombosiscan.bsky.social · 25/06/2026

Early Bird registration ends July 1. If you've been thinking about joining us in Montreal this November, now is a great time to secure your place. Join colleagues from across the country for a day focused on the decisions that matter most in thrombosis care. thrombosiscanada.ca/2026Conference

000

Thrombosis Canada @thrombosiscan.bsky.social · 22/06/2026

Clinical Pearl from CLOT Conversations: "Hormone therapy should not automatically be discontinued following VTE." Dr. Shannon Bates and Dr. Leslie Skeith discuss why continuation of hormone therapy may be appropriate and where discontinuation is not. www.buzzsprout.com/1946680/epis...

000

Thrombosis Canada @thrombosiscan.bsky.social · 19/06/2026

New CLOT Conversations episode! How do estrogen, progesterone, and testosterone influence thrombosis risk? Dr. Leslie Skeith and Dr. Shannon Bates discuss their recent NEJM review and what clinicians need to know. Listen Here: www.buzzsprout.com/1946680/epis... #Thrombosis #VTE #WomensHealth

000

Thrombosis Canada @thrombosiscan.bsky.social · 18/06/2026

Hormone therapy is a common part of clinical care, but not all hormone therapies carry the same thrombosis risk. In this podcast episode, our hosts speak with Dr. Leslie Skeith and Dr. Shannon Bates about their recent @NEJM review on the subject. Listen: www.buzzsprout.com/1946680/epis...

000

Thrombosis Canada @thrombosiscan.bsky.social · 12/06/2026

Rapid-Fire Updates brings together five concise presentations focused on questions clinicians encounter every day. Practical takeaways. Expert faculty. Real-world relevance. November 7, 2026 | Montreal Register: thrombosiscanada.ca/hcp/education/cpd/tc_conference

010